Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

365

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: S-309309
DRUG: Placebo

Sponsor

Shionogi